Christina Blackwell

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses<i>In Vivo</i>

Rocío Montes de, Alireza Alavi, Nick Vitali et al. · Molecular Cancer Therapeutics · 2021 · 99 citations · Full text

Inhibition of FGF/FGFR autocrine signaling in mesothelioma with the FGF ligand trap, FP-1039/GSK3052230

Christina Blackwell, Christian Sherk, Maggie Fricko et al. · Oncotarget · 2016 · 39 citations · Full text

PF558 THE ANTI-BCMA ANTIBODY-DRUG CONJUGATE GSK2857916 DRIVES IMMUNOGENIC CELL DEATH AND IMMUNE-MEDIATED ANTI-TUMOR RESPONSES, AND IN COMBINATION WITH AN OX40 AGONIST POTENTIATES IN VIVO ACTIVITY

Rocío Montes de, Sabyasachi Bhattacharya, Nick Vitali et al. · HemaSphere · 2019 · 17 citations · Full text

Apoptosis, Immunology, Immunoediting +18

Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade

Sapna Yadavilli, Jeremy D. Waight, Sara Brett et al. · Cancer Research Communications · 2023 · 15 citations · Full text